This study aims to review the available literature pertinent to vascular complications in
COVID-19. A systematic search was performed using PubMed and Google Scholar to …

Abstract Severe coronavirus (COVID-19) infection has been reportedly associated with a
high risk of thromboembolism. Developing macrovascular thrombotic complications …

Background Patients with coronavirus disease 2019 (Covid-19) may experience venous
thrombosis while data regarding arterial thrombosis are sparse. Methods Prospective …

Introduction COVID-19 associated VTE is a new disease entity with high morbidity and
mortality. The aim of this paper is to review contemporary emerging literature on the …

Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

Arterial thrombotic disease (atherosclerotic cardiovascular disease, CVD) and venous
thromboembolism (VTE)(comprising of deep vein thrombosis (DVT) and pulmonary …

The current COVID-19 pandemic emerged in December 2019, in China, affecting millions of
people worldwide. COVID-19 is mainly a disease of the respiratory system, yet systematic …

Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

Introduction The first patients with Coronavirus disease 2019 (COVID-19) emerged at the
end of 2019. This novel viral infection demonstrated unique features that include …

Thrombotic complications of the novel coronavirus (COVID-19) are a concerning aspect of
the disease, due to the high incidence in critically ill patients and poor clinical outcomes …